China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Illumina Inc

    • Johnson & Johnson

    • Nova Biomedical

    • Micronit

    • QIAGEN

    • Guangzhou Kingmed Diagnostics Center Co Ltd

    • Eli Lilly & Company

    • Siemens

    • Kindstar Global

    • Accriva

    • ADICON Clinical Laboratories (Privately held)

    • Zhejiang Di’an Diagnostics Technology Co, Ltd

    • Thermo Fisher Scientific Inc

    • GE

    By Type:

    • Precision Medicine

    • Interventional Cardiology

    • Point of Care Devices

    • Molecular Diagnostics

    By Application:

    • Clinic

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Overview 2018-2029

    • 1.1 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry Development Overview

    • 1.2 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry Development History

    • 1.3 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry Market Size (2018-2029)

    • 1.4 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Analysis by Type from Production Side

      • 1.4.1 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume, Production Value and Growth Rate of Precision Medicine (2018-2029)

      • 1.4.2 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume, Production Value and Growth Rate of Interventional Cardiology (2018-2029)

      • 1.4.3 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume, Production Value and Growth Rate of Point of Care Devices (2018-2029)

      • 1.4.4 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume, Production Value and Growth Rate of Molecular Diagnostics (2018-2029)

    • 1.5 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Analysis by Application from Consumption End

      • 1.5.1 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.2 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Analysis by Region

      • 1.6.1 North China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

    Chapter 2 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Status and Competition Analysis in 2023

      • 2.2.3 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry Development

    Chapter 3 Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional CardiologyIndustry Chain Analysis

    • 3.1 Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry Chain

    • 3.2 Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market

    • 3.3 Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market

    Chapter 4 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Type

    • 4.1 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Total Production Volume and Growth Rate from Production Side

    • 4.5 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume and Growth Rate, by Type

      • 4.5.1 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume and Growth Rate of Precision Medicine

      • 4.5.2 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume and Growth Rate of Interventional Cardiology

      • 4.5.3 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume and Growth Rate of Point of Care Devices

      • 4.5.4 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume and Growth Rate of Molecular Diagnostics

    Chapter 5 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Total Market Size and Growth Rate from Consumption End

    • 5.5 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate, by Application

      • 5.5.1 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate of Clinic

      • 5.5.2 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate of Hospital

    Chapter 6 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Region

    • 6.1 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume and Production Value, by Region

    • 6.2 China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume and Sales Value, by Region

    Chapter 7 North China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Analysis

    • 7.1 North China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Type

    • 7.2 North China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Application

    Chapter 8 Central China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Analysis

    • 8.1 Central China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Type

    • 8.2 Central China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Application

    Chapter 9 South China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Analysis

    • 9.1 South China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Type

    • 9.2 South China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Application

    Chapter 10 East China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Analysis

    • 10.1 East China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Type

    • 10.2 East China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Application

    Chapter 11 Northeast China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Analysis

    • 11.1 Northeast China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Type

    • 11.2 Northeast China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Application

    Chapter 12 Southwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Analysis

    • 12.1 Southwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Type

    • 12.2 Southwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Application

    Chapter 13 Northwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Analysis

    • 13.1 Northwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Type

    • 13.2 Northwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Illumina Inc

        • 14.1.1 Illumina Inc Company Profile

        • 14.1.2 Illumina Inc Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Johnson & Johnson

        • 14.2.1 Johnson & Johnson Company Profile

        • 14.2.2 Johnson & Johnson Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Nova Biomedical

        • 14.3.1 Nova Biomedical Company Profile

        • 14.3.2 Nova Biomedical Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Micronit

        • 14.4.1 Micronit Company Profile

        • 14.4.2 Micronit Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 QIAGEN

        • 14.5.1 QIAGEN Company Profile

        • 14.5.2 QIAGEN Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Guangzhou Kingmed Diagnostics Center Co Ltd

        • 14.6.1 Guangzhou Kingmed Diagnostics Center Co Ltd Company Profile

        • 14.6.2 Guangzhou Kingmed Diagnostics Center Co Ltd Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Eli Lilly & Company

        • 14.7.1 Eli Lilly & Company Company Profile

        • 14.7.2 Eli Lilly & Company Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Siemens

        • 14.8.1 Siemens Company Profile

        • 14.8.2 Siemens Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Kindstar Global

        • 14.9.1 Kindstar Global Company Profile

        • 14.9.2 Kindstar Global Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Accriva

        • 14.10.1 Accriva Company Profile

        • 14.10.2 Accriva Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 ADICON Clinical Laboratories (Privately held)

        • 14.11.1 ADICON Clinical Laboratories (Privately held) Company Profile

        • 14.11.2 ADICON Clinical Laboratories (Privately held) Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Zhejiang Di’an Diagnostics Technology Co, Ltd

        • 14.12.1 Zhejiang Di’an Diagnostics Technology Co, Ltd Company Profile

        • 14.12.2 Zhejiang Di’an Diagnostics Technology Co, Ltd Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Thermo Fisher Scientific Inc

        • 14.13.1 Thermo Fisher Scientific Inc Company Profile

        • 14.13.2 Thermo Fisher Scientific Inc Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 GE

        • 14.14.1 GE Company Profile

        • 14.14.2 GE Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Performance

        • 14.14.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry Research Conclusions

    • 15.2 Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry Market Size (2018-2029)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume, Production Value and Growth Rate of Precision Medicine (2018-2029)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume, Production Value and Growth Rate of Interventional Cardiology (2018-2029)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume, Production Value and Growth Rate of Point of Care Devices (2018-2029)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume, Production Value and Growth Rate of Molecular Diagnostics (2018-2029)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

    • Figure Central China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

    • Figure South China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

    • Figure East China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate from 2018-2029

    • Figure Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Share by Type in 2018

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Share by Type in 2023

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume and Growth Rate of Precision Medicine (2018-2023)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume and Growth Rate of Interventional Cardiology (2018-2023)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume and Growth Rate of Point of Care Devices (2018-2023)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume and Growth Rate of Molecular Diagnostics (2018-2023)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Share by Application in 2018

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Share by Application in 2023

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Total Market Size and Growth Rate from Consumption End

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume by Region (2018-2023)

    • Table China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Region (2018-2023)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Region (2018-2023)

    • Table China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Value by Region (2018-2023)

    • Table China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Value Share by Region (2018-2023)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Value Share by Region (2018-2023)

    • Table China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume by Region (2018-2023)

    • Table China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Region (2018-2023)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Region (2018-2023)

    • Table China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Value by Region (2018-2023)

    • Table China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Value Share by Region (2018-2023)

    • Figure China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Value Share by Region (2018-2023)

    • Table North China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume by Type (2018-2023)

    • Table North China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Figure North China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Table North China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume by Application (2018-2023)

    • Table North China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Figure North China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Table Central China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume by Type (2018-2023)

    • Table Central China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Figure Central China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Table Central China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume by Application (2018-2023)

    • Table Central China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Figure Central China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Table South China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume by Type (2018-2023)

    • Table South China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Figure South China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Table South China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume by Application (2018-2023)

    • Table South China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Figure South China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Table East China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume by Type (2018-2023)

    • Table East China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Figure East China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Table East China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume by Application (2018-2023)

    • Table East China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Figure East China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Table Northeast China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume by Type (2018-2023)

    • Table Northeast China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Figure Northeast China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Table Northeast China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume by Application (2018-2023)

    • Table Northeast China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Table Southwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume by Type (2018-2023)

    • Table Southwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Figure Southwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Table Southwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume by Application (2018-2023)

    • Table Southwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Table Northwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume by Type (2018-2023)

    • Table Northwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Figure Northwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Production Volume Share by Type (2018-2023)

    • Table Northwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume by Application (2018-2023)

    • Table Northwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Sales Volume Share by Application (2018-2023)

    • Table Illumina Inc Company Profile

    • Table Illumina Inc Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table Nova Biomedical Company Profile

    • Table Nova Biomedical Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table Micronit Company Profile

    • Table Micronit Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table QIAGEN Company Profile

    • Table QIAGEN Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table Guangzhou Kingmed Diagnostics Center Co Ltd Company Profile

    • Table Guangzhou Kingmed Diagnostics Center Co Ltd Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly & Company Company Profile

    • Table Eli Lilly & Company Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table Siemens Company Profile

    • Table Siemens Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table Kindstar Global Company Profile

    • Table Kindstar Global Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table Accriva Company Profile

    • Table Accriva Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table ADICON Clinical Laboratories (Privately held) Company Profile

    • Table ADICON Clinical Laboratories (Privately held) Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table Zhejiang Di’an Diagnostics Technology Co, Ltd Company Profile

    • Table Zhejiang Di’an Diagnostics Technology Co, Ltd Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table Thermo Fisher Scientific Inc Company Profile

    • Table Thermo Fisher Scientific Inc Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)

    • Table GE Company Profile

    • Table GE Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.